deucravacitinib, deucravacitinib, Deucravacitinib placebo 2mg film-coated tablets in sachet, oral use, deucravacitinib
IM011-1071
Phase 3 small_molecule active
Quick answer
deucravacitinib, deucravacitinib, Deucravacitinib placebo 2mg film-coated tablets in sachet, oral use, deucravacitinib for Juvenile Psoriatic Arthritis (JPsA) is a Phase 3 program (small_molecule) at Bristol-Myers Squibb / Pfizer EEIG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bristol-Myers Squibb / Pfizer EEIG
- Indication
- Juvenile Psoriatic Arthritis (JPsA)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active